Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Public-Private Roles in the Pharmaceutical Sector - Implications for Equitable Access and Rational Drug Use - Health Economics and Drugs Series, No. 005
(1997; 115 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAuthors
View the documentAcknowledgements
View the documentAbbreviations and Acronyms
View the documentExecutive summary
Open this folder and view contents1. Public and private roles in the pharmaceutical sector
Open this folder and view contents2. Pharmaceutical markets: structure and performance
Open this folder and view contents3. Essential state responsibilities
Open this folder and view contents4. The public-private mix in drug markets: a global picture1
Open this folder and view contents5. Market mechanisms in public drug supply
Open this folder and view contents6. Promoting public health needs through the private sector
Open this folder and view contents7. Pharmaceutical production and public-private roles
Open this folder and view contents8. Capacity-building and the process of change
Open this folder and view contents9. Managing public-private roles
View the documentReferences
View the documentGlossary
View the documentBack Cover
 

Public-Private Roles in the Pharmaceutical Sector - Implications for Equitable Access and Rational Drug Use - Health Economics and Drugs Series, No. 005

WHO/DAP/97.12
Original: English
Distribution: Limited

Health Economics and Drugs
DAP Series No. 5

World Health Organization
Action Programme on Essential Drugs

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014